Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 3/2003

01-03-2003 | Original Article

Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET

Authors: Susanne Nikolaus, Rolf Larisch, Markus Beu, Farhad Forutan, Henning Vosberg, Hans-Wilhelm Müller-Gärtner

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 3/2003

Login to get access

Abstract

Unilateral destruction of the substantia nigra by local application of 6-hydroxydopamine (6-OHDA) serves as an animal model for Parkinson's disease. In this study, the changes in neostriatal dopamine D2 receptor density were investigated with a small animal positron emission tomograph (PET) before and after 6-OHDA lesion. PET scans were performed in 14 rats after injection of the D2 receptor radioligand [18F] N-methylbenperidol. After the first scan (day 0), nigrostriatal pathways were lesioned by unilateral injections of 6-OHDA. Further PET scans were performed on days 2 and 14 post-lesion. For both striata, B max values were determined from saturation binding curves with non-linear regression analysis. In the striatum ipsilateral to the lesion, B max initially amounted to 19.3±1. 9 fmol/mg (mean±SD) and increased to 19.7±2.2 and 29.9±5.7 fmol/mg on days 2 and 14 post-lesion, respectively. Contralateral B max values increased from 19.2±2 fmol/mg prior to the lesion to 21.2±2.9 and 28.6±5.7 fmol/mg on days 2 and 14, respectively. On day 14, the ipsilateral saturation binding curve differed from the ipsilateral pre-lesion curve ( P =0.04; F test). When the contralateral pre-lesion saturation binding curve was compared with the contralateral post-lesion curve on day 14, a P value of 0.08 was obtained. This first serial in vivo imaging study of 6-OHDA-lesioned rats showed a time-dependent increase in striatal D2 receptor density on both sides, the increase being more pronounced ipsilateral to the lesion. This result implies that compensatory mechanisms in the intact hemisphere contribute to regenerative processes following nigrostriatal dopaminergic denervation. Overall, our findings show the feasibility of repetitive in vivo studies of striatal receptor density with a small animal tomograph. Moreover, the applied in vivo saturation binding technique provides a versatile method for the quantification of time-dependent changes in the concentration of receptor binding sites.
Literature
1.
go back to reference Chatziioannou AF. Molecular imaging of small animals with dedicated PET tomographs. Eur J Nucl Med 2002; 29:98–114.CrossRef Chatziioannou AF. Molecular imaging of small animals with dedicated PET tomographs. Eur J Nucl Med 2002; 29:98–114.CrossRef
2.
go back to reference Weber S, Bauer A, Herzog H, et al. Recent results of the TierPET scanner. IEEE Trans Nucl Sci 2000; 47:1665–1669.CrossRef Weber S, Bauer A, Herzog H, et al. Recent results of the TierPET scanner. IEEE Trans Nucl Sci 2000; 47:1665–1669.CrossRef
3.
go back to reference Nikolaus S, Larisch R, Beu M, et al. Imaging of striatal dopamine D2 receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with [18F](3-N-methyl)benperidol. J Nucl Med 2001; 42:1691–1696.PubMed Nikolaus S, Larisch R, Beu M, et al. Imaging of striatal dopamine D2 receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with [18F](3-N-methyl)benperidol. J Nucl Med 2001; 42:1691–1696.PubMed
4.
go back to reference Nikolaus S, Larisch R, Bier D, et al. In vivo-Messung der striatalen D2-Rezeptordichte und Affinität mit einem Kleintier-PET und [18F] N-Methyl-Benperidol. In: Brink I, Högerle S, Moser E, eds. Nuklearmedizin als Paradigma molekularer Bildgebung. Berlin: Blackwell; 2002:24. Nikolaus S, Larisch R, Bier D, et al. In vivo-Messung der striatalen D2-Rezeptordichte und Affinität mit einem Kleintier-PET und [18F] N-Methyl-Benperidol. In: Brink I, Högerle S, Moser E, eds. Nuklearmedizin als Paradigma molekularer Bildgebung. Berlin: Blackwell; 2002:24.
5.
go back to reference Schwarting RKW, Huston JP. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog Neurobiol 1996; 49:215–266.PubMed Schwarting RKW, Huston JP. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog Neurobiol 1996; 49:215–266.PubMed
6.
go back to reference Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand 1991; 367:69–93. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand 1991; 367:69–93.
7.
go back to reference Neve KA, Kozlowski MR, Marshall JF. Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity. Brain Res 1982; 244:33–44.PubMed Neve KA, Kozlowski MR, Marshall JF. Plasticity of neostriatal dopamine receptors after nigrostriatal injury: relationship to recovery of sensorimotor functions and behavioral supersensitivity. Brain Res 1982; 244:33–44.PubMed
8.
go back to reference Neve KA, Altar CA, Wong CA, et al. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury. Brain Res 1984; 302:9–18.PubMed Neve KA, Altar CA, Wong CA, et al. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury. Brain Res 1984; 302:9–18.PubMed
9.
go back to reference Staunton DA, Wolfe BB, Groves PM, Molinoff PB. Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior. Brain Res 1981; 211:315–327.PubMed Staunton DA, Wolfe BB, Groves PM, Molinoff PB. Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior. Brain Res 1981; 211:315–327.PubMed
10.
go back to reference Ferré S, Fuxe K. Dopamine denervation leads to an increase in the intramembrane interactions between adenosine A2 and dopamine D2 receptors in the neostriatum. Brain Res 1992; 595:124–130. Ferré S, Fuxe K. Dopamine denervation leads to an increase in the intramembrane interactions between adenosine A2 and dopamine D2 receptors in the neostriatum. Brain Res 1992; 595:124–130.
11.
go back to reference Hume SP, Opacka-Juffry J, Myers R, et al. Effect of L-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum quantified using PET. Synapse 1995; 21:45–53.PubMed Hume SP, Opacka-Juffry J, Myers R, et al. Effect of L-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum quantified using PET. Synapse 1995; 21:45–53.PubMed
12.
go back to reference Nguyen TV, Brownell AL, Chen YCI, et al. Detection of the effects of dopamine receptor sensitivity using pharmacological MRI and correlations with PET. Synapse 2000; 36:57–65.CrossRefPubMed Nguyen TV, Brownell AL, Chen YCI, et al. Detection of the effects of dopamine receptor sensitivity using pharmacological MRI and correlations with PET. Synapse 2000; 36:57–65.CrossRefPubMed
13.
go back to reference Phelps ME. Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci USA 2000; 97:9226–9233.PubMed Phelps ME. Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci USA 2000; 97:9226–9233.PubMed
14.
go back to reference Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic Press, 1986. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Sydney: Academic Press, 1986.
15.
go back to reference Moerlein SM, Banks WR, Parkinson D. Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral receptor binding. Appl Radiat Isot 1992; 43:913–917.CrossRef Moerlein SM, Banks WR, Parkinson D. Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral receptor binding. Appl Radiat Isot 1992; 43:913–917.CrossRef
16.
go back to reference Beu M, Nikolaus S, Larisch R, Weber S, Vosberg H, Müller-Gärtner HW. Ein Algorithmus zur Quantifizierung des Einflusses der Harderschen Drüse auf die striatale Aktivität bei PET-Messungen an der Ratte. Nuklearmedizin 2000; 39:162. Beu M, Nikolaus S, Larisch R, Weber S, Vosberg H, Müller-Gärtner HW. Ein Algorithmus zur Quantifizierung des Einflusses der Harderschen Drüse auf die striatale Aktivität bei PET-Messungen an der Ratte. Nuklearmedizin 2000; 39:162.
17.
go back to reference Antonini A, Schwarz J, Oertel WH, et al. [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors. Neurology 1994; 44:1325–1329.PubMed Antonini A, Schwarz J, Oertel WH, et al. [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors. Neurology 1994; 44:1325–1329.PubMed
18.
go back to reference Ichise M, Kim YJ, Ballinger JR, et al. SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD. Neurology 1999; 52:1206–1214.PubMed Ichise M, Kim YJ, Ballinger JR, et al. SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD. Neurology 1999; 52:1206–1214.PubMed
19.
go back to reference Kaasinen V, Ruottinen HM, Nagren K, et al. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C]raclopride and [11C]methylspiperone. J Nucl Med 2000; 41:65–70.PubMed Kaasinen V, Ruottinen HM, Nagren K, et al. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C]raclopride and [11C]methylspiperone. J Nucl Med 2000; 41:65–70.PubMed
20.
go back to reference Sawle GV, Playford ED, Brooks DJ, et al. Asymmetrical pre-synaptic and post-synaptic changes in the striatal dopamine projection in dopa naive parkinsonism: diagnostic implications of the D2 receptor status. Brain 1993; 116:853–867.PubMed Sawle GV, Playford ED, Brooks DJ, et al. Asymmetrical pre-synaptic and post-synaptic changes in the striatal dopamine projection in dopa naive parkinsonism: diagnostic implications of the D2 receptor status. Brain 1993; 116:853–867.PubMed
21.
go back to reference Mishra RK, Marshall AM, Varmuza SL. Supersensitivity in rat caudate nucleus: effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes. Brain Res 1980; 200:47–57.PubMed Mishra RK, Marshall AM, Varmuza SL. Supersensitivity in rat caudate nucleus: effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes. Brain Res 1980; 200:47–57.PubMed
22.
go back to reference Narang N, Wamsley JK. Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain. J Chem Neuroanat 1995; 9:41–53.CrossRefPubMed Narang N, Wamsley JK. Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain. J Chem Neuroanat 1995; 9:41–53.CrossRefPubMed
23.
go back to reference Chalon S, Edmond P, Bodard S, et al. Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markersin a rat model of Parkinson's disease. Synapse 1999; 31:134–139.CrossRefPubMed Chalon S, Edmond P, Bodard S, et al. Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markersin a rat model of Parkinson's disease. Synapse 1999; 31:134–139.CrossRefPubMed
24.
go back to reference Guerin B, Silice C, Mouchet P, Feuerstein C, Demenge P. Changes of the striatal 3H-spiperone binding 3–6 weeks after nigrostriatal denervation and after two years. Life Sci 1985; 37:953–961.PubMed Guerin B, Silice C, Mouchet P, Feuerstein C, Demenge P. Changes of the striatal 3H-spiperone binding 3–6 weeks after nigrostriatal denervation and after two years. Life Sci 1985; 37:953–961.PubMed
25.
go back to reference Pan HS, Penney JB, Young AB. Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. J Neurochem 1985; 45:1396–1404. Pan HS, Penney JB, Young AB. Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. J Neurochem 1985; 45:1396–1404.
26.
go back to reference Feuerstein C, Demenge P, Caron P, Barrette G, Guerin B, Mouchet P. Supersensitivity time course of dopamine antagonist binding after nigrostriatal denervation: evidence for early and drastic changes in the rat corpus striatum. Brain Res 1981; 226:221–234.PubMed Feuerstein C, Demenge P, Caron P, Barrette G, Guerin B, Mouchet P. Supersensitivity time course of dopamine antagonist binding after nigrostriatal denervation: evidence for early and drastic changes in the rat corpus striatum. Brain Res 1981; 226:221–234.PubMed
27.
go back to reference Nikolaus S, Huston JP, Körber B, Thiel C, Schwarting RKW. Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion. Peptides 1997; 18:1161–1168.CrossRefPubMed Nikolaus S, Huston JP, Körber B, Thiel C, Schwarting RKW. Pretreatment with neurokinin substance P but not with cholecystokinin-8S can alleviate functional deficits of partial nigrostriatal 6-hydroxydopamine lesion. Peptides 1997; 18:1161–1168.CrossRefPubMed
28.
go back to reference Pritzel M, Huston JP, Sarter M. Behavioral and neuronal reorganization after unilateral substantia nigra lesions: evidence for increased interhemispheric nigrostriatal projections. Neuroscience 1983; 9:879–888.PubMed Pritzel M, Huston JP, Sarter M. Behavioral and neuronal reorganization after unilateral substantia nigra lesions: evidence for increased interhemispheric nigrostriatal projections. Neuroscience 1983; 9:879–888.PubMed
Metadata
Title
Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET
Authors
Susanne Nikolaus
Rolf Larisch
Markus Beu
Farhad Forutan
Henning Vosberg
Hans-Wilhelm Müller-Gärtner
Publication date
01-03-2003
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 3/2003
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-002-1056-2

Other articles of this Issue 3/2003

European Journal of Nuclear Medicine and Molecular Imaging 3/2003 Go to the issue